Robustness of the Autophagy Pathway to Somatic Copy Number Losses

Pierfrancesco Polo1, Niklas Gremke1,2, Thorsten Stiewe1,3,4

  • 1Institute of Molecular Oncology, Philipps-University, 35043 Marburg, Germany.

Cells
|June 10, 2022
PubMed

Insights

Cancer cells with defects in autophagy genes (ATGs) may be vulnerable to metabolic drugs. However, even with copy number losses, the autophagy pathway remains robust, limiting therapeutic potential.

Area of Science:

  • Cellular Biology
  • Cancer Metabolism
  • Molecular Oncology

Background:

  • Autophagy is a cellular process that replenishes metabolites during energy stress, potentially sensitizing cancer cells to metabolic drugs.
  • Defects in autophagy could indicate a metabolically vulnerable cancer state, creating a therapeutic window.
  • While mutations in autophagy genes (ATGs) are rare, copy number losses frequently affect ATGs in various cancers.

Purpose of the Study:

  • To investigate the impact of autophagy gene copy number loss on cancer cell sensitivity to drugs targeting aerobic glycolysis.
  • To determine if reduced ATG copy numbers create a metabolic vulnerability in non-small cell lung cancer cells.

Main Methods:

  • Utilized CRISPR/Cas9 technology to delete varying numbers of copies of key autophagy genes (MAP1LC3B/ATG8F, BECN1/ATG6, ATG10) in non-small cell lung cancer cells.
  • Assessed the sensitivity of modified cancer cells to compounds targeting aerobic glycolysis.
  • Analyzed protein levels and p62 accumulation in cancer patients with ATG copy number loss to evaluate autophagic flux.

Main Results:

  • Complete knockout of a single ATG gene blocked autophagy and induced significant metabolic vulnerability.
  • Combinations of different nonhomozygous ATG deletions did not result in a similar blockade or vulnerability.
  • In cancer patients, ATG copy number loss had a blunted effect at the protein level, with no significant p62 accumulation indicating reduced autophagic flux.

Conclusions:

  • The autophagy pathway exhibits remarkable robustness and resilience, even when key autophagy genes experience copy number loss.
  • Concomitant copy number losses of multiple autophagy genes do not necessarily lead to a functionally impaired autophagy pathway or increased metabolic vulnerability in cancer.
  • The resilience of autophagy suggests that targeting this pathway through copy number alterations alone may not be a universally effective anticancer strategy.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Genome Copying Errors02:46

Genome Copying Errors

DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their  survival. Therefore, the copying errors are checked and repaired at three levels.
4.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.1K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.4K